Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial

Autor: Sternberg, Cora N, Castellano, Daniel, Daugaard, Gedske, Géczi, Lajos, Hotte, Sebastien J, Mainwaring, Paul N, Saad, Fred, Souza, Ciro, Tay, Miah H, Garrido, José M Tello, Galli, Luca, Londhe, Anil, De Porre, Peter, Goon, Betty, Lee, Emma, McGowan, Tracy, Naini, Vahid, Todd, Mary B, Molina, Arturo, George, Daniel J
Zdroj: In Lancet Oncology October 2014 15(11):1263-1268
Databáze: ScienceDirect